Cargando…
Immune response after intermittent minimally invasive intraocular pressure elevations in an experimental animal model of glaucoma
BACKGROUND: Elevated intraocular pressure (IOP), as well as fluctuations in IOP, is a main risk factor for glaucoma, but its pathogenic effect has not yet been clarified. Beyond the multifactorial pathology of the disease, autoimmune mechanisms seem to be linked to retinal ganglion cell (RGC) death....
Autores principales: | Gramlich, Oliver W., Teister, Julia, Neumann, Mareike, Tao, Xue, Beck, Sabine, von Pein, Harald D., Pfeiffer, Norbert, Grus, Franz H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4836145/ https://www.ncbi.nlm.nih.gov/pubmed/27090083 http://dx.doi.org/10.1186/s12974-016-0542-6 |
Ejemplares similares
-
Decelerated neurodegeneration after intravitreal injection of α-synuclein antibodies in a glaucoma animal model
por: Teister, J., et al.
Publicado: (2017) -
Intravitreal injection of β-crystallin B2 improves retinal ganglion cell survival in an experimental animal model of glaucoma
por: Anders, Fabian, et al.
Publicado: (2017) -
Glaucoma related Proteomic Alterations in Human Retina Samples
por: Funke, Sebastian, et al.
Publicado: (2016) -
A Monoclonal Anti-HMGB1 Antibody Attenuates Neurodegeneration in an Experimental Animal Model of Glaucoma
por: Tonner, Henrik, et al.
Publicado: (2022) -
Modulation of the Immune System for the Treatment of Glaucoma
por: Bell, Katharina, et al.
Publicado: (2018)